Document is current
Any future updates will be listed below
-
Authors
Frey, Samuel
Goronflot, Thomas
Blanchard, Claire
Kerleau, Clarisse
Gourraud, Pierre-Antoine
Wargny, Matthieu
Caillard, Cécile
Hourmant, Maryvonne
Figueres, Lucile
Mirallié, Éric
,
Blancho, Gilles
Branchereau, Julien
Cantarovich, Diego
Chapelet, Agnès
Dantal, Jacques
Deltombe, Clément
Figueres, Lucile
Garandeau, Claire
Giral, Magali
Gourraud-Vercel, Caroline
Hourmant, Maryvonne
Karam, Georges
Kerleau, Clarisse
Meurette, Aurélie
Ville, Simon
Kandell, Christine
Moreau, Anne
Renaudin, Karine
Cesbron, Anne
Delbos, Florent
Walencik, Alexandre
Devis, Anne
Amrouche, Lucile
Anglicheau, Dany
Aubert, Olivier
Bererhi, Lynda
Legendre, Christophe
Loupy, Alexandre
Martinez, Frank
Sberro-Soussan, Rébecca
Scemla, Anne
Tinel, Claire
Zuber, Julien
Eschwege, Pascal
Frimat, Luc
Girerd, Sophie
Hubert, Jacques
Ladriere, Marc
Laurain, Emmanuelle
Leblanc, Louis
Lecoanet, Pierre
Lemelle, Jean-Louis
Badet, Lionel
Brunet, Maria
Buron, Fanny
Cahen, Rémi
Daoud, Sameh
Fournie, Coralie
Grégoire, Arnaud
Koenig, Alice
Lévi, Charlène
Morelon, Emmanuel
Pouteil-Noble, Claire
Rimmelé, Thomas
Thaunat, Olivier
Delmas, Sylvie
Garrigue, Valérie
Le Quintrec, Moglie
Pernin, Vincent
Serre, Jean-Emmanuel
- License Information
-
More Information
Article History
Received: 25 April 2021
Accepted: 11 May 2022
First Online: 21 May 2022
Declarations
:
: The French DIVAT cohort was approved by the CNIL, n°914184.
: All participants gave informed consent.
: All authors approved the last version of the manuscript and gave their consent for publication.
: PA Gourraud is the founder (2008) () and the co-founder of Wedata (2018) (). He is consulting for major pharmaceuticals companies all dealt with through academic pipelines (AstraZeneca, Biogen, Boston Scientific, Cook, Edimark, Ellipses, Elsevier, Methodomics, Merck, Mérieux, Sanofi-Genzyme, WeData). He has no prescription activity neither drugs nor devices. The other authors have no conflicts of interest to disclose.
